Alzheimers Disease Diagnostics and Therapeutics Market 2027 By Product Type, End User and Geography | The Insight Partners

Alzheimers Disease Diagnostics and Therapeutics Market to 2027 - Global Analysis and Forecasts By Product Type (Therapeutics, Diagnostics); End User (Hospitals, Clinics) and Geography

Report Code: TIPRE00004836 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Alzheimers disease is a chronic condition that starts slowly but progressively spreads over the time. It leads to loss of memory and loss of mental functions. Patients suffering from this disease exhibit symptoms such as vision loss, difficulty in planning and solving problems, weak decision making ability and others. There is no particular therapy to cure Alzheimer disease, however some of the therapies helps to reduce the symptoms and can increase lifespan of such person.

MARKET DYNAMICS
The Alzheimers disease diagnostics and therapeutics market is expected to grow in coming years owing to rise in aging population, increase in incidence of neurodegenerative diseases, increase in research and development investment, and high rate of neurological disorders. On the other hand, significant number of drugs in pipeline for the treatment and diagnosis for Alzheimers disease is likely to offer growth opportunities for the players operating in the market.

MARKET SCOPE
The "Global Alzheimers Disease Diagnostics and Therapeutics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of Alzheimers disease diagnostics and therapeutics market with detailed market segmentation by product type, end users, and geography. The global Alzheimers disease diagnostics and therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Alzheimers disease diagnostics and therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Alzheimers disease diagnostics and therapeutics market is segmented on the basis of product type, and end user. Based on product type, the market is segmented as therapeutics and diagnostics. Further according to therapeutics the market is segmented as cholinesterase inhibitors and NMDA receptor antagonist, and according to diagnostic the market is segmented as lumbar puncture test, computed tomography (CT) scan, magnetic resonance imaging (MRI), electroencephalography (EEG), positron emission tomography (PET) scan, and others. On the basis of end user, the global Alzheimers disease diagnostics and therapeutics market is segmented into hospitals and clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Alzheimers disease diagnostics and therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Alzheimers disease diagnostics and therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Alzheimers disease diagnostics and therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Alzheimers disease diagnostics and therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Alzheimers disease diagnostics and therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Alzheimers disease diagnostics and therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for Alzheimers disease diagnostics and therapeutics in the global market. Below mentioned is the list of few companies engaged in the Alzheimers disease diagnostics and therapeutics market.

The report also includes the profiles of key Alzheimers disease diagnostics and therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Pfizer Inc.
  • Eisai Co., Ltd
  • Novartis AG
  • H. Lundbeck A/S
  • ALLERGAN
  • TauRx
  • AC Immune
  • Johnson and Johnson.
  • AbbVie Inc.
  • Eli Lilly and Company
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Alzheimers Disease Diagnostics and Therapeutics Market - By Product Type
1.3.2 Alzheimers Disease Diagnostics and Therapeutics Market - By End User
1.3.3 Alzheimers Disease Diagnostics and Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. THERAPEUTICS
7.3.1. Overview
7.3.2. Therapeutics Market Forecast and Analysis
7.3.3. Cholinesterase inhibitors Market
7.3.3.1. Overview
7.3.3.2. Cholinesterase Inhibitors Market Forecast and Analysis
7.3.4. NMDA Receptor Antagonist Market
7.3.4.1. Overview
7.3.4.2. NMDA Receptor Antagonist Market Forecast and Analysis
7.4. DIAGNOSTICS
7.4.1. Overview
7.4.2. Diagnostics Market Forecast and Analysis
7.4.3. Lumbar Puncture Test Market
7.4.3.1. Overview
7.4.3.2. Lumbar Puncture Test Market Forecast and Analysis
7.4.4. Computed Tomography (CT) Scan Market
7.4.4.1. Overview
7.4.4.2. Computed Tomography (CT) Scan Market Forecast and Analysis
7.4.5. Magnetic Resonance Imaging (MRI) Market
7.4.5.1. Overview
7.4.5.2. Magnetic Resonance Imaging (MRI) Market Forecast and Analysis
7.4.6. Electroencephalography (EEG) Market
7.4.6.1. Overview
7.4.6.2. Electroencephalography (EEG) Market Forecast and Analysis
7.4.7. Positron Emission Tomography (PET) Scan Market
7.4.7.1. Overview
7.4.7.2. Positron Emission Tomography (PET) Scan Market Forecast and Analysis
7.4.8. Others Market
7.4.8.1. Overview
7.4.8.2. Others Market Forecast and Analysis
8. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
9. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Alzheimers Disease Diagnostics And Therapeutics Market Overview
9.1.2 North America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis
9.1.3 North America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Product Type
9.1.4 North America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By End User
9.1.5 North America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Alzheimers disease Diagnostics and Therapeutics Market
9.1.5.1.1 United States Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.1.5.1.2 United States Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.1.5.2 Canada Alzheimers disease Diagnostics and Therapeutics Market
9.1.5.2.1 Canada Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.1.5.2.2 Canada Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.1.5.3 Mexico Alzheimers disease Diagnostics and Therapeutics Market
9.1.5.3.1 Mexico Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.1.5.3.2 Mexico Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.2. EUROPE
9.2.1 Europe Alzheimers Disease Diagnostics And Therapeutics Market Overview
9.2.2 Europe Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis
9.2.3 Europe Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Product Type
9.2.4 Europe Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By End User
9.2.5 Europe Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Alzheimers disease Diagnostics and Therapeutics Market
9.2.5.1.1 Germany Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.2.5.1.2 Germany Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.2.5.2 France Alzheimers disease Diagnostics and Therapeutics Market
9.2.5.2.1 France Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.2.5.2.2 France Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.2.5.3 Italy Alzheimers disease Diagnostics and Therapeutics Market
9.2.5.3.1 Italy Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.2.5.3.2 Italy Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.2.5.4 Spain Alzheimers disease Diagnostics and Therapeutics Market
9.2.5.4.1 Spain Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.2.5.4.2 Spain Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.2.5.5 United Kingdom Alzheimers disease Diagnostics and Therapeutics Market
9.2.5.5.1 United Kingdom Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.2.5.5.2 United Kingdom Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Alzheimers Disease Diagnostics And Therapeutics Market Overview
9.3.2 Asia-Pacific Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Alzheimers disease Diagnostics and Therapeutics Market
9.3.5.1.1 Australia Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.3.5.1.2 Australia Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.3.5.2 China Alzheimers disease Diagnostics and Therapeutics Market
9.3.5.2.1 China Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.3.5.2.2 China Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.3.5.3 India Alzheimers disease Diagnostics and Therapeutics Market
9.3.5.3.1 India Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.3.5.3.2 India Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.3.5.4 Japan Alzheimers disease Diagnostics and Therapeutics Market
9.3.5.4.1 Japan Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.3.5.4.2 Japan Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.3.5.5 South Korea Alzheimers disease Diagnostics and Therapeutics Market
9.3.5.5.1 South Korea Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.3.5.5.2 South Korea Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Alzheimers Disease Diagnostics And Therapeutics Market Overview
9.4.2 Middle East and Africa Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Alzheimers disease Diagnostics and Therapeutics Market
9.4.5.1.1 South Africa Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.4.5.1.2 South Africa Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.4.5.2 Saudi Arabia Alzheimers disease Diagnostics and Therapeutics Market
9.4.5.2.1 Saudi Arabia Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.4.5.2.2 Saudi Arabia Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.4.5.3 U.A.E Alzheimers Disease Diagnostics and Therapeutics Market
9.4.5.3.1 U.A.E Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.4.5.3.2 U.A.E Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Alzheimers Disease Diagnostics And Therapeutics Market Overview
9.5.2 South and Central America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Alzheimers Disease Diagnostics And Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Alzheimers disease Diagnostics and Therapeutics Market
9.5.5.1.1 Brazil Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.5.5.1.2 Brazil Alzheimers Disease Diagnostics And Therapeutics Market by End User
9.5.5.2 Argentina Alzheimers disease Diagnostics and Therapeutics Market
9.5.5.2.1 Argentina Alzheimers Disease Diagnostics And Therapeutics Market by Product Type
9.5.5.2.2 Argentina Alzheimers Disease Diagnostics And Therapeutics Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. Alzheimers DISEASE DIAGNOSTICS AND THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EISAI CO., LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. H. LUNDBECK A/S
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ALLERGAN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TAURX
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. AC IMMUNE
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. JOHNSON AND JOHNSON.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ABBVIE INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ELI LILLY AND COMPANY
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Eisai Co., Ltd
3. Novartis AG
4. H. Lundbeck A/S
5. ALLERGAN
6. TauRx
7. AC Immune
8. Johnson and Johnson.
9. AbbVie Inc.
10. Eli Lilly and Company